IGF-1 analogue

IGF-1 LR3.

A long-acting version of IGF-1 — powerful on paper, essentially untested in humans, and carrying serious theoretical risks.

IGF-1 analogueInvestigationalSourced profile
Read this first

This is educational information, not medical advice, and The Peptide University does not sell peptides, supplies, or supplements. Many compounds discussed here are sold as “research chemicals” and are not approved for human use outside of clinical trials. Laws vary by country, and nothing here is a recommendation to obtain or use anything. Talk to a qualified clinician about your own situation.

● Investigational — not approved for human use

IGF-1 LR3 (Long R3 IGF-1) is a modified, long-acting analogue of insulin-like growth factor 1. It's an experimental compound with no approved human use.

How it works

IGF-1 is the downstream signal of growth hormone that drives tissue growth. The LR3 modification extends its half-life and reduces binding to carrier proteins, so more stays active — a potent anabolic signal.

The evidence

There's a well-defined mechanism and strong preclinical rationale for muscle growth, but essentially no human clinical data for the physique uses it's marketed for. The gap between animal promise and human proof is wide.

Safety

Two serious concerns stand out: effects on blood glucose regulation (IGF-1 has insulin-like actions) and the theoretical risk of accelerating growth of existing tumors, since IGF-1 is a growth signal. These are reasons for real caution.

FAQ

QIs it the same as taking growth hormone?

No — it's the downstream growth factor itself, in a long-acting form, rather than the hormone that triggers it.

QWhat's the tumor concern?

IGF-1 promotes cell growth, so raising it is theorized to potentially accelerate any existing cancer — a reason experts urge caution.

Sources

This profile summarizes the following. Follow the links to read the originals — and remember that summaries age, so check for newer information.

Inclusion here is not endorsement of any source's claims; several are cited so you can compare how different outlets characterize the same evidence.

Questions & comments

No account, no login — leave a name or stay anonymous. Ask a question, add something the article missed, or answer someone else. Be kind and cite sources where you can.